These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11808525)

  • 41. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
    Souka AP; Krampl E; Bakalis S; Heath V; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):9-17. PubMed ID: 11489218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased fetal nuchal translucency: possible involvement of early cardiac failure.
    Montenegro N; Matias A; Areias JC; Castedo S; Barros H
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):265-8. PubMed ID: 9383878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prenatal diagnosis of 22q11 microdeletion in an early second-trimester fetus with conotruncal anomaly presenting with increased nuchal translucency and bilateral intracardiac echogenic foci.
    Machlitt A; Tennstedt C; Körner H; Bommer C; Chaoui R
    Ultrasound Obstet Gynecol; 2002 May; 19(5):510-3. PubMed ID: 11982988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fetal cardiac anomalies and genetic syndromes.
    Pajkrt E; Weisz B; Firth HV; Chitty LS
    Prenat Diagn; 2004 Dec; 24(13):1104-15. PubMed ID: 15614851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fetal echocardiography and congenital heart disease.
    Mapp T
    Prof Care Mother Child; 2000; 10(1):9-11. PubMed ID: 11013567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does gender have an impact on the sonographic detection of second-trimester fetuses with Down's syndrome?
    Benacerraf BR; Miller WA; Nadel A; Pauker S; Bromley B
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):30-3. PubMed ID: 7850586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy.
    Prefumo F; Bhide A; Thilaganathan B; Carvalho JS
    Ultrasound Obstet Gynecol; 2005 Apr; 25(4):405-8. PubMed ID: 15747330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Outcome of fetuses with malformations discovered before 14 weeks. Where the discovery is revealed by echography during the first trimester, is it responsible for the voluntary termination of the pregnancy? Comparison before and after July 2001].
    Mangione R; Fries N; Godard P; Fontanges M; Haddad G; Mirlesse V;
    J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):154-62. PubMed ID: 18036748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased nuchal translucency and normal karyotype: coping with uncertainty.
    Bilardo CM
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):99-101. PubMed ID: 11251914
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased nuchal translucency as a prenatal manifestation of congenital adrenal hyperplasia.
    Masturzo B; Hyett JA; Kalache KD; Rumsby G; Jauniaux E; Rodeck CH
    Prenat Diagn; 2001 Apr; 21(4):314-6. PubMed ID: 11288125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy.
    Smrcek JM; Gembruch U; Krokowski M; Berg C; Krapp M; Geipel A; Germer U
    Arch Gynecol Obstet; 2003 Jun; 268(2):94-101. PubMed ID: 12768297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased nuchal translucency in fetuses with a normal karyotype.
    Hyett JA
    Prenat Diagn; 2002 Oct; 22(10):864-8. PubMed ID: 12378566
    [No Abstract]   [Full Text] [Related]  

  • 57. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk.
    Bahado-Singh RO; Oz UA; Kovanci E; Deren O; Feather M; Hsu CD; Copel JA; Mahoney MJ
    J Matern Fetal Med; 1999; 8(2):37-43. PubMed ID: 10090488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased nuchal translucency and CATCH 22.
    Lazanakis MS; Rodgers K; Economides DL
    Prenat Diagn; 1998 May; 18(5):507-10. PubMed ID: 9621387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for fetal congenital heart disease.
    Pham A; Melchior M
    CMAJ; 2017 Mar; 189(12):E468. PubMed ID: 28385862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.